| VectorY B.V.. (6/15/21). "Press Release: VectorY Raises €31 Million in Seed Financing to Develop Next-Generation Gene Therapies Aimed at Muscular and CNS Disorders". Amsterdam. |
2021-06-15 |
| iTeos Therapeutics Inc.. (6/14/21). "Press Release: iTeos Therapeutics and GSK Announce Development and Commercialisation Collaboration for EOS-448, an anti-TIGIT Monoclonal Antibody, Enabling Novel Next-generation Immuno-oncology Combinations". Gosselie |
2021-06-14 |
| Atai Life Sciences B.V.. (6/11/21). "Press Release: Atai Life Sciences Announces Launch of Initial Public Offering". Berlin. |
2021-06-11 |
| Argenx SE. (6/7/21). "Press Release: Argenx to Regain Global Rights to Cusatuzumab". Breda. |
2021-06-07 |
| Innovative Molecules GmbH. (6/7/21). "Press Release: Innovative Molecules Raises €20 Million Series A Equity Financing Round". Munich. |
2021-06-07 |
| ImaginAb, Inc.. (6/3/21). "Press Release: ImaginAb Completes $12.8 Million Financing to Accelerate Growth Plans". Los Angeles, CA & San Diego, CA. |
2021-06-03 |
| Amyl Therapeutics. (6/3/21). "Press Release: Amyl Therapeutics Closes €18.3 Million Series A Financing to Develop Novel Therapies for Amyloidosis". Liège. |
2021-06-03 |
| Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht. |
2021-06-02 |
| Argenx SE. (6/1/21). "Press Release: Argenx Appoints Karl Gubitz as Chief Financial Officer". Dublin. |
2021-06-01 |
| Moderna, Inc.. (6/1/21). "Press Release: Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands". Albstadt. |
2021-06-01 |
| Origin.Bio GmbH. (5/26/21). "Press Release: Origin.Bio Secures $15 Million Funding Led by EQT Ventures to Help Manufacturers Create a more Sustainable Future". Munich. |
2021-05-26 |
| Ziphius Vaccines N.V.. (5/25/21). "Press Release: Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing". |
2021-05-25 |
| Numab Therapeutics AG. (5/20/21). "Press Release: Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing". Wädenswil (Zurich). |
2021-05-20 |
| Hummingbird Bioscience. (5/18/21). "Press Release: Hummingbird Bioscience Raises US$125 Million in Series C Financing". Singapore. |
2021-05-18 |
| Forbion Capital Partners. (5/18/21). "Press Release: Forbion Expands Team with New General Partner". Naarden. |
2021-05-18 |
| Ginkgo Bioworks Inc.. (5/17/21). "Press Release: Ginkgo Bioworks Announces Agreement to Acquire Fungal Platform Technology Company Dutch DNA". Boston, MA. |
2021-05-17 |
| Inari. (5/12/21). "Press Release: Inari Raises Over $200 Million to Unlock the Full Potential of Seed". Cambridge, MA. |
2021-05-12 |
| Droia Ventures. (5/11/21). "Press Release: Droia Ventures Raises a New Fund of EUR 220 Million to Target Genetic Diseases and Expands Leadership Team with George Golumbeski". Brussels. |
2021-05-11 |
| Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen. |
2021-05-06 |
| Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen. |
2021-04-29 |
| CytoSmart Technologies B.V.. (4/28/21). "Press Release: CytoSmart Redefines Automated Cell Counting with a New Fluorescence Cell Counter". Eindhoven. |
2021-04-28 |
| CytoSmart Technologies B.V.. (4/28/21). "Press Release: CytoSmart Announces a U.S. Subsidiary". Eindhoven. |
2021-04-28 |
| Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam. |
2021-04-28 |
| Molecular Partners AG. (4/23/21). "Press Release: Molecular Partners Files Registration Statement for Proposed Initial Public Offering in the United States". Zürich-Schlieren. |
2021-04-23 |
| Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden. |
2021-04-22 |
| Forbion Capital Partners. (4/20/21). "Press Release: Forbion Announces Final Close of Forbion Growth Opportunities Fund I at EUR 360 Million (USD 428 Million)". Naarden & Munich. |
2021-04-20 |
| Inari. (4/20/21). "Press Release: Dr. Sophie V. Vandebroek, Noted Tech Leader, Joins Inari Board of Directors". Cambridge, MA. |
2021-04-20 |
| Rinri Therapeutics Ltd.. (4/20/21). "Press Release: Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss". Sheffield. |
2021-04-20 |
| Forbion Capital Partners. (4/16/21). "Press Release: Forbion Appoints Head of Communications". Amsterdam. |
2021-04-16 |
| Lumicks Technologies B.V.. (4/16/21). "Press Release: Lumicks Raises $93 Million in Series D Financing". Amsterdam. |
2021-04-16 |
| Royal Philips. (4/8/21). "Press Release: Philips and Ibex Medical Analytics Team to Accelerate Adoption of AI-powered Digital Pathology". Amsterdam & Tel Aviv. |
2021-04-08 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. |
2021-03-26 |
| Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams |
2021-03-25 |
| Lava Therapeutics B.V.. (3/24/21). "Press Release: Lava Therapeutics Announces Pricing of Initial Public Offering". Utrecht & Philadelphia, PA. |
2021-03-24 |
| Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". |
2021-03-23 |
| Augustine Therapeutics. (3/23/21). "Press Release: Augustine Therapeutics Awarded EUR 1.2 Million VLAIO Research Grant to Develop New Medicines for Neuromuscular Diseases". Leuven. |
2021-03-23 |
| Augustine Therapeutics. (3/19/21). "Press Release: Augustine Therapeutics Strengthens Board of Directors and Sets Up Scientific Advisory Board". Leuven. |
2021-03-19 |
| Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. |
2021-03-18 |
| Augustine Therapeutics. (3/18/21). "Press Release: Augustine Therapeutics Appoints Sylvain Celanire as CEO to Accelerate Development of Innovative Medicines for Rare Neuromuscular Diseases". Leuven. |
2021-03-18 |
| Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
| ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. |
2021-03-16 |
| Lava Therapeutics B.V.. (3/15/21). "Press Release: Lava Therapeutics B.V. Appoints Edward F. Smith as Chief Financial Officer". Utrecht & Philadelphia, PA. |
2021-03-15 |
| Univercells S.A.. (3/15/21). "Press Release: Univercells, Univercells Technologies and Gamma Biosciences Announce Mathias Garny as New CEO of Univercells Technologies". Brussels. |
2021-03-15 |
| AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. |
2021-03-10 |
| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| Royal Philips. (3/2/21). "Press Release: Shez Partovi to Succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer". Amsterdam. |
2021-03-02 |
| Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. |
2021-03-01 |
| Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. |
2021-03-01 |
| Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". |
2021-02-25 |
| Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. |
2021-02-23 |
| Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. |
2021-02-23 |
| InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht. |
2021-02-16 |
| CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2021-02-12 |
| Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. |
2021-02-10 |
| Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen. |
2021-02-10 |
| Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". |
2021-02-08 |
| V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. |
2021-02-04 |
| Tecan Group Ltd.. (2/4/21). "Press Release: Tecan and UgenTec Partner to Offer Sample-to-result Solutions for qPCR". Männedorf. |
2021-02-04 |
| Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". |
2021-02-03 |
| Hyloris Pharmaceuticals S.A.. (2/3/21). "Press Release: Hyloris Appoints Marieke Vermeersch as VP of Investor Relations and Corporate Communications". Liège. |
2021-02-03 |
| GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. |
2021-02-03 |
| Nyxoah S.A.. (2/2/21). "Press Release: Nyxoah and Vanderbilt University Enter Exclusive Licensing Agreement Regarding Next Generation Neurostimulation Technologies to Treat Obstructive Sleep Apnea (OSA)". Mont-Saint-Guibert. |
2021-02-02 |
| Argen-X N.V. (Argenx). (2/2/21). "Press Release: Argenx Raises $1.0 Billion in Gross Proceeds in a Global Offering". Breda. |
2021-02-02 |
| Medigene AG. (1/28/21). "Press Release: Focus on Solid Tumors – Discontinuation of MDG1021 Development Program". Planegg-Martinsried. |
2021-01-28 |
| CureVac N.V.. (1/28/21). "Press Release: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-28 |
| High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases". |
2021-01-26 |
| CureVac N.V.. (1/25/21). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-25 |
| BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem. |
2021-01-21 |
| Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-21 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies". Indianapolis, IN & Utrecht. |
2021-01-19 |
| Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. |
2021-01-19 |
| Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA. |
2021-01-15 |
| Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
| Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. |
2021-01-15 |
| NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. |
2021-01-14 |
| UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. |
2021-01-13 |
| Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg. |
2021-01-12 |
| Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. |
2021-01-12 |
| Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. |
2021-01-11 |
| Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. |
2021-01-11 |
| Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. |
2021-01-08 |
| CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA. |
2021-01-07 |
| BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. |
2021-01-07 |
| Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. |
2021-01-07 |
| Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. |
2021-01-07 |
| Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. |
2021-01-06 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht. |
2021-01-06 |
| Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. |
2021-01-06 |
| Siemens Healthineers AG. (1/5/21). "Press Release: Siemens Healthineers Proposes Peer Schatz to Annual Shareholders' Meeting as New Supervisory Board Member". Erlangen. |
2021-01-05 |
| MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. |
2021-01-05 |
| Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille. |
2021-01-05 |
| Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. |
2021-01-04 |
| BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
| BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
| Swedish Orphan Biovitrum AB. (12/21/20). "Press Release: Sobi Appoints New Head of North America Ahead of Launch Phase". |
2020-12-21 |
| Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. |
2020-12-21 |
| Univercells S.A.. (12/17/20). "Press Release: Univercells Holding Raises €70 Million in Series C Financing". Brussels. |
2020-12-17 |
| Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. |
2020-12-15 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
